World's Largest Resource for Cardiovascular Perfusion

+1 888-499-5672 Login

Twenty Years of Vasoplegic Syndrome Treatment in Heart Surgery. Methylene Blue Revised

Main Zone, Mobile Zone, Perfusion Zone

1 min read

Objective: This study was conducted to reassess the concepts established over the past 20 years, in particular in the last 5 years, about the use of methylene blue in the treatment of vasoplegic syndrome in cardiac surgery.

Methods: A wide literature review was carried out using the data extracted from: MEDLINE, SCOPUS and ISI WEB OF SCIENCE.

Results: The reassessed and reaffirmed concepts were 1) MB is safe in the recommended doses (the lethal dose is 40 mg/kg); 2) MB does not cause endothelial dysfunction; 3) The MB effect appears in cases of NO up-regulation; 4) MB is not a vasoconstrictor, by blocking the cGMP pathway it releases the cAMP pathway, facilitating the norepinephrine vasoconstrictor effect; 5) The most used dosage is 2 mg/kg as IV bolus, followed by the same continuous infusion because plasma concentrations sharply decrease in the first 40 minutes; and 6) There is a possible “window of opportunity” for MB’s effectiveness. In the last five years, major challenges were: 1) Observations about side effects; 2) The need for prophylactic and therapeutic guidelines, and; 3) The need for the establishment of the MB therapeutic window in humans.

Conclusion: MB action to treat vasoplegic syndrome is time-dependent. Therefore, the great challenge is the need, for the establishment the MB therapeutic window in humans. This would be the first step towards a systematic guideline to be followed by possible multicenter studies.

Epic Staffing

Leave a Reply Cancel reply

You must be logged in to post a comment.

You may also like

Blood Management, Main Zone, Mobile Zone, Perfusion Zone

Safety and Effects of Two Red Blood Cell Transfusion Strategies in Pediatric Cardiac Surgery Patients: A Randomized Controlled Trial

For patients with a non-cyanotic congenital heart defect undergoing elective cardiac surgery, a restrictive RBC transfusion policy (threshold of Hb 8.0 g/dl) during the entire perioperative period is safe, leads to a shorter hospital stay and is less expensive.

1 min read

Main Zone, Mobile Zone, Perfusion Zone

Training Residents in Off-pump Coronary Artery Bypass Surgery: A 14-year Experience

OPCAB is a safe and reproducible surgical technique that can be taught successfully to cardiothoracic trainees.

1 min read

Perfusion Zone, Tiny Perfusion Letter

The International Society for Minimally Invasive Cardiothoracic Surgery Expert Consensus Statement on Transcatheter and Surgical Aortic Valve Replacement in Low- and Intermediate-Risk Patients: A Meta-Analysis of Randomized and Propensity-Matched Studies

In RCTs comparing TAVR and SAVR in low-risk patients, early mortality and stroke were lower in TAVR, but did not differ at 1 year. There was no difference in mortality and stroke in intermediate-risk patients. The Multidisciplinary Heart Team must consider individual patient characteristics and preferences when recommending TAVR or SAVR. The decision must consider the long-term management of each patient’s aortic valve disease.

1 min read